Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.46946 | 18 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.45419 | 19 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.45507 | 19 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.41273 | 19 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.4052 | 19 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.48236 | 17 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.57029 | 23 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.43262 | 19 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.43023 | 19 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.44679 | 19 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.43753 | 19 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.43738 | 19 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.4481 | 19 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.4412 | 19 |